Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

BIO Notebook Day 1: Other Therapeutic Areas Left Behind As Deal-Making, Financing Focus On Oncology, Rare Diseases

Jun 05 2018

• By Joseph Haas

BIO International 2018 Notebook

Related Content

Forty Seven's IO Antibody Attracts Two Big Pharma Partners

Jan 15 2018

Trillium Looks To Lead The Immuno-Oncology Pack In CD47 Inhibition

Oct 11 2016

Nothing Is Undruggable: Novartis' Bradner On CAR-T, CRISPR & DNA Libraries

Feb 01 2017

Related Companies

Trillium Therapeutics Inc.

Bristol Myers Squibb Company

Surface Oncology, Inc.

Forty Seven Inc.

Genentech, Inc.

Amgen, Inc.

Harvard University

Dana-Farber/Harvard Cancer Center

Novartis AG

Novartis AG

Additional Topics

Business Strategies Financing Deals Commercial BioPharmaceutical

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window